Microneedles for controlled and sustained intraocular drug delivery
Source abstract
Abstract
Abstract Microneedles (MNs) have emerged as a promising technology for minimally invasive drug delivery, offering significant advantages in the treatment of ocular diseases. These miniaturized needles enable precise, localized drug delivery directly into specific tissues of the eye, such as the cornea, sclera, vitreous, or retina, while minimizing pain and discomfort. MNs can be fabricated from various biocompatible materials, including metals, silicon, and biodegradable polymers, making them highly adaptable to various clinical applications. Recent advancements in MN design include the integration of 3D printing technologies to create highly customized geometries for improved drug delivery precision, the use of smart materials that enable stimuli-responsive and sustained drug release, and the development of hybrid microneedles combining different polymers to enhance both mechanical strength and controlled drug release. These innovations have established MNs as a superior alternative to traditional methods like eye drops or intravitreal injections, which often face issues of limited bioavailability and patient compliance. This review summarizes the current state of research on MN-based ocular drug delivery, focusing on material developments, fabrication methods, drug release mechanisms, and implantation techniques. Future directions for MN technology in ophthalmology are also discussed, highlighting its potential to improve treatment outcomes for complex ocular diseases.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Ocular Surface and Contact Lens · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Sabri, A. H. et al. Expanding the applications of microneedles in dermatology. Eur. J. Pharm. Biopharm. 140, 121–140 (2019).10.1016/j.ejpb.2019.05.001 ↗
2. Park, H., Park, W. & Lee, C. H. Electrochemically active materials and wearable biosensors for the in situ analysis of body fluids for human healthcare. NPG Asia Mater. 13, 23 (2021).10.1038/s41427-020-00280-x ↗
3. Himawan, A. et al. Where Microneedle Meets Biomarkers: Futuristic Application for Diagnosing and Monitoring Localized External Organ Diseases. Adv. Healthc. Mater. 12, 2202066 (2023).10.1002/adhm.202202066 ↗
4. Zheng, M., Sheng, T., Yu, J., Gu, Z. & Xu, C. Microneedle biomedical devices. Nat. Rev. Bioeng. 2, 324–342 (2024).10.1038/s44222-023-00141-6 ↗
5. Glover, K. et al. Microneedles for advanced ocular drug delivery. Adv. Drug. Deliv. Rev. 201, 115082 (2023).10.1016/j.addr.2023.115082 ↗
6. Bao, Q. et al. Advances in Polysaccharide-Based Microneedle Systems for the Treatment of Ocular Diseases. Nanomicro. Lett. 16, 268 (2024).
7. Al-Nimry, S. & Abu Dayah, A. Implication of microneedles for ocular drug delivery systems. J. Drug. Deliv. Sci. Technol. 98, 105841 (2024).10.1016/j.jddst.2024.105841 ↗
8. Gadziński, P. et al. Microneedle-based ocular drug delivery systems – recent advances and challenges. Beilstein J. Nanotechnol. 13, 1167–1184 (2022).10.3762/bjnano.13.98 ↗
9. Yang, Y. & Lockwood, A. Topical ocular drug delivery systems: Innovations for an unmet need. Exp. Eye. Res. 218, 109006 (2022).10.1016/j.exer.2022.109006 ↗
10. Jager, R. D., Aiello, L. P., Patel, S. C. & Cunningham, E. T. Jr Risks of intravitreous injection: a comprehensive review. Retina 24, 676–698 (2004).10.1097/00006982-200410000-00002 ↗
11. Jung, J. H., Chiang, B., Grossniklaus, H. E. & Prausnitz, M. R. Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle. J. Control. Release 277, 14–22 (2018).10.1016/j.jconrel.2018.03.001 ↗
12. Kumbhar, P. et al. Treatment avenues for age-related macular degeneration: breakthroughs and bottlenecks. Ageing Res. Rev. 98, 102322 (2024).10.1016/j.arr.2024.102322 ↗
13. Addo, R. T. Ocular drug delivery: Advances, challenges and applications. Ocular Drug Delivery: Advances, Challenges and Applications (Springer International Publishing, 2016).10.1007/978-3-319-47691-9 ↗
14. Tsung, T. H., Chen, Y. H. & Lu, D. W. Updates on biodegradable formulations for ocular drug delivery. Pharmaceutics 15, 734 (2023).10.3390/pharmaceutics15030734 ↗
15. Chen, B. Z. et al. Strategies to develop polymeric microneedles for controlled drug release. Adv. Drug. Deliv. Rev. 203, 115109 (2023).10.1016/j.addr.2023.115109 ↗
16. Al-Qaysi, Z. K. et al. Sustained release ocular drug delivery systems for glaucoma therapy. Expert Opin. Drug Deliv. 20, 905–919 (2023).10.1080/17425247.2023.2219053 ↗
17. Kang, H. et al. The most promising microneedle device: present and future of hyaluronic acid microneedle patch. Drug Deliv. 29, 3087–3110 (2022).10.1080/10717544.2022.2125600 ↗
18. Than, A. et al. Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery. Nat. Commun. 9, 4433 (2018).10.1038/s41467-018-06981-w ↗
19. Liu, F., Cheng, Z. & Yi, H. NIR light-activatable dissolving microneedle system for melanoma ablation enabled by a combination of ROS-responsive chemotherapy and phototherapy. J. Nanobiotechnology 21, 61 (2023).10.1186/s12951-023-01815-4 ↗
20. Berillo, D. et al. Stimuli-responsive polymers for transdermal, transmucosal and ocular drug delivery. Pharmaceutics 13, 2050 (2021).10.3390/pharmaceutics13122050 ↗
21. Soliman, K. A., Ullah, K., Shah, A., Jones, D. S. & Singh, T. R. R. Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications. Drug Discov. Today 24, 1575–1586 (2019).10.1016/j.drudis.2019.05.036 ↗
22. Li, R. et al. 3D-printed microneedle arrays for drug delivery. J. Control. Release 350, 933–948 (2022).10.1016/j.jconrel.2022.08.022 ↗
23. Talha, M. et al. Long term and electrochemical corrosion investigation of cold worked AISI 316L and 316LVM stainless steels in simulated body fluid. RSC Adv. 4, 13340–13349 (2014).10.1039/c3ra47881e ↗
24. Fekry, A. M., El-Kamel, R. S. & Ghoneim, A. A. Electrochemical behavior of surgical 316L stainless steel eye glaucoma shunt (Ex-PRESS) in artificial aqueous humor. J. Mater. Chem. B 4, 4542–4548 (2016).10.1039/C6TB00712K ↗
25. Li, W., Zhang, Y. & Chen, J. Design, fabrication and characterization of in-plane titanium microneedles for transdermal drug delivery. Key Eng. Mater. 483, 532–536 (2011).10.4028/www.scientific.net/KEM.483.532 ↗
26. Khandan, O., Kahook, M. Y. & Rao, M. P. Fenestrated microneedles for ocular drug delivery. Sens. Actuators B Chem. 223, 15–23 (2016).10.1016/j.snb.2015.09.071 ↗
27. Jiang, J. et al. Coated microneedles for drug delivery to the eye. Invest. Ophthalmol. Vis. Sci. 48, 4038–4043 (2007).10.1167/iovs.07-0066 ↗
28. Kim, Y. C., Grossniklaus, H. E., Edelhauser, H. F. & Prausnitz, M. R. Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 55, 7376–7386 (2014).10.1167/iovs.14-15257 ↗
29. Khandan, O., Famili, A., Kahook, M. Y. & Rao, M. P. Titanium-based, fenestrated, in-plane microneedles for passive ocular drug delivery. in 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 6572–6575 (2012).10.1109/EMBC.2012.6347500 ↗
30. Chen, B., Wei, J., Tay, F. E. H., Wong, Y. T. & Iliescu, C. Silicon microneedle array with biodegradable tips for transdermal drug delivery. Microsyst. Technol. 14, 1015–1019 (2008).10.1007/s00542-007-0530-y ↗
31. Gardeniers, H. J. G. E. et al. Silicon micromachined hollow microneedles for transdermal liquid transport. J. Microelectromechanical Syst. 12, 855–862 (2003).10.1109/JMEMS.2003.820293 ↗
32. Abser, M. N. Solid Silicon Microneedles for Safe and Effective Drug Delivery to Human Eye. J. Electr. Eng. 36, 28–34 (2009).
33. Zainal Abidin, H. E. et al. Stress and Deformation of Optimally Shaped Silicon Microneedles for Transdermal Drug Delivery. J. Pharm. Sci. 109, 2485–2492 (2020).10.1016/j.xphs.2020.04.019 ↗
34. Kim, H. et al. Bioresorbable, Miniaturized Porous Silicon Needles on a Flexible Water-Soluble Backing for Unobtrusive, Sustained Delivery of Chemotherapy. ACS Nano 14, 7227–7236 (2020).10.1021/acsnano.0c02343 ↗
35. Park, W. et al. Transparent Intracellular Sensing Platform with Si Needles for Simultaneous Live Imaging. ACS Nano 17, 25014–25026 (2023).10.1021/acsnano.3c07527 ↗
36. Park, W. et al. Biodegradable silicon nanoneedles for ocular drug delivery. Sci. Adv. 8, eabn1772 (2022).10.1126/sciadv.abn1772 ↗
37. Wang, Z. et al. Novel biomaterial strategies for controlled growth factor delivery for biomedical applications. NPG Asia Mater. 9, e435 (2017).10.1038/am.2017.171 ↗
38. Tyler, B., Gullotti, D., Mangraviti, A., Utsuki, T. & Brem, H. Polylactic acid (PLA) controlled delivery carriers for biomedical applications. Adv. Drug. Deliv. Rev. 107, 163–175 (2016).10.1016/j.addr.2016.06.018 ↗
39. Makadia, H. K. & Siegel, S. J. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3, 1377–1397 (2011).10.3390/polym3031377 ↗
40. Elsawy, M. A., Kim, K. H., Park, J. W. & Deep, A. Hydrolytic degradation of polylactic acid (PLA) and its composites. Renew. Sustain. Energy Rev. 79, 1346–1352 (2017).10.1016/j.rser.2017.05.143 ↗
41. Farah, S., Anderson, D. G. & Langer, R. Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review. Adv. Drug Deliv. Rev. 107, 367–392 (2016).10.1016/j.addr.2016.06.012 ↗
42. Lee, K. J. et al. Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery. Acta Biomater. 80, 48–57 (2018).10.1016/j.actbio.2018.09.039 ↗
43. Lee, Y. J., Park, S. H., Kim, S. I. L., Lee, K. J. & Ryu, W. H. Rapidly Detachable Microneedles Using Porous Water-Soluble Layer for Ocular Drug Delivery. Adv. Mater. Technol. 5, 1901145 (2020).10.1002/admt.201901145 ↗
44. Lee, K. J. et al. Self-Plugging Microneedle (SPM) for Intravitreal Drug Delivery. Adv. Healthc. Mater. 11, 2102599 (2022).10.1002/adhm.202102599 ↗
45. Necas, J., Bartosikova, L., Brauner, P. & Kolar, J. Hyaluronic acid (hyaluronan): a review. Vet., Med 53, 397–411 (2008).10.17221/1930-VETMED ↗
46. Jabbari, F., Babaeipour, V. & Saharkhiz, S. Comprehensive review on biosynthesis of hyaluronic acid with different molecular weights and its biomedical applications. Int. J. Biol. Macromol. 240, 124484 (2023).10.1016/j.ijbiomac.2023.124484 ↗
47. Chandra, N. S., Gorantla, S., Priya, S. & Singhvi, G. Insight on updates in polysaccharides for ocular drug delivery. Carbohydr. Polym. 297, 120014 (2022).10.1016/j.carbpol.2022.120014 ↗
48. Eom, Y. et al. Self-sealing hyaluronic acid-coated 30-gauge intravitreal injection needles for preventing vitreous and drug reflux through needle passage. Sci. Rep. 11, 16996 (2021).10.1038/s41598-021-96561-8 ↗
49. Zheng, M. et al. In situ-formed cryomicroneedles for intradermal cell delivery. NPG Asia Mater. 16, 11 (2024).10.1038/s41427-024-00531-1 ↗
50. Snetkov, P., Zakharova, K., Morozkina, S., Olekhnovich, R. & Uspenskaya, M. Hyaluronic acid: The influence of molecular weight on structural, physical, physico-chemical, and degradable properties of biopolymer. Polymers 12, 1800 (2020).10.3390/polym12081800 ↗
51. Shi, H. et al. A Rapid Corneal Healing Microneedle for Efficient Ocular Drug Delivery. Small 18, 2104657 (2022).10.1002/smll.202104657 ↗
52. Li, W. et al. Rapidly separable microneedle patch for the sustained release of a contraceptive. Nat. Biomed. Eng. 3, 220–229 (2019).10.1038/s41551-018-0337-4 ↗
53. Thakur, R. R. S. et al. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery. Drug Deliv. Transl. Res. 6, 800–815 (2016).10.1007/s13346-016-0332-9 ↗
54. Datta, D., Roy, G., Garg, P. & Venuganti, V. V. K. Ocular delivery of cyclosporine A using dissolvable microneedle contact lens. J. Drug Deliv. Sci. Technol. 70, 103211 (2022).10.1016/j.jddst.2022.103211 ↗
55. Albadr, A. A. et al. Rapidly dissolving microneedle patch of amphotericin B for intracorneal fungal infections. Drug Deliv. Transl. Res. 12, 931–943 (2022).10.1007/s13346-021-01032-2 ↗
56. Mahfufah, U. et al. Incorporation of Inclusion Complexes in the Dissolvable Microneedle Ocular Patch System for the Efficiency of Fluconazole in the Therapy of Fungal Keratitis. ACS Appl. Mater. Interfaces 16, 25637–25651 (2024).10.1021/acsami.3c19482 ↗
57. Fitaihi, R., Abukhamees, S., Orlu, M. & Craig, D. Q. M. Transscleral Delivery of Dexamethasone-Loaded Microparticles Using a Dissolving Microneedle Array. Pharmaceutics 15, 1622 (2023).10.3390/pharmaceutics15061622 ↗
58. Kong, B. et al. Frozen reinforced microneedles loaded with NIR-photothermal nanozyme for keratitis treatment. Nano Today 52, 102000 (2023).10.1016/j.nantod.2023.102000 ↗
59. Thakur, R. R. S., Fallows, S. J., McMillan, H. L., Donnelly, R. F. & Jones, D. S. Microneedle-mediated intrascleral delivery of in situ forming thermoresponsive implants for sustained ocular drug delivery. J. Pharm. Pharmacol. 66, 584–595 (2014).10.1111/jphp.12152 ↗
60. Kim, J. H. et al. Impact insertion of transfer-molded microneedle for localized and minimally invasive ocular drug delivery. J. Control. Release 209, 272–279 (2015).10.1016/j.jconrel.2015.04.041 ↗
61. Tucak, A. et al. Microneedles: Characteristics, materials, production methods and commercial development. Micromachines 11, 961 (2020).10.3390/mi11110961 ↗
62. Bhatnagar, S., Reddy Gadeela, P., Thathireddy, P., Vamsi, K. & Venuganti, V. Microneedle-based drug delivery: materials of construction. J. Chem. Sci. 131, 1–28 (2019).10.1007/s12039-019-1666-x ↗
63. Wang, Q. et al. Investigation on fabrication process of dissolving microneedle arrays to improve effective needle drug distribution. Eur. J. Pharm. Sci. 66, 148–156 (2015).10.1016/j.ejps.2014.09.011 ↗
64. Larrañeta, E., Lutton, R. E. M., Woolfson, A. D. & Donnelly, R. F. Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development. Mater. Sci. Eng. R. 104, 1–32 (2016).10.1016/j.mser.2016.03.001 ↗
65. Wang, Q. L., Zhu, D. D., Chen, Y. & Guo, X. D. A fabrication method of microneedle molds with controlled microstructures. Mater. Sci. Eng. C. 65, 135–142 (2016).10.1016/j.msec.2016.03.097 ↗
66. Lee, J. W., Park, J. H. & Prausnitz, M. R. Dissolving microneedles for transdermal drug delivery. Biomaterials 29, 2113–2124 (2008).10.1016/j.biomaterials.2007.12.048 ↗
67. Sullivan, S. P., Murthy, N. & Prausnitz, M. R. Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv. Mater. 20, 933–938 (2008).10.1002/adma.200701205 ↗
68. Lee, K. J. et al. Non-transdermal microneedles for advanced drug delivery. Adv. Drug Deliv. Rev. 165, 41–59 (2020).10.1016/j.addr.2019.11.010 ↗
69. Bok, M., Zhao, Z. J., Jeon, S., Jeong, J. H. & Lim, E. Ultrasonically and Iontophoretically Enhanced Drug-Delivery System Based on Dissolving Microneedle Patches. Sci. Rep. 10, 2027 (2020).10.1038/s41598-020-58822-w ↗
70. Wang, C., Ye, Y., Hochu, G. M., Sadeghifar, H. & Gu, Z. Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody. Nano Lett. 16, 2334–2340 (2016).10.1021/acs.nanolett.5b05030 ↗
71. Chen, M. C., Lin, Z. W. & Ling, M. H. Near-infrared light-activatable microneedle system for treating superficial tumors by combination of chemotherapy and photothermal therapy. ACS Nano 10, 93–101 (2016).10.1021/acsnano.5b05043 ↗
72. Tran, K. T. M. et al. Transdermal microneedles for the programmable burst release of multiple vaccine payloads. Nat. Biomed. Eng. 5, 998–1007 (2021).10.1038/s41551-020-00650-4 ↗
73. Wu, K. Y., Joly-Chevrier, M., Akbar, D. & Tran, S. D. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems. Pharmaceutics 15, 1094 (2023).10.3390/pharmaceutics15041094 ↗
74. Akhter, M. H. et al. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Gels 8, 82 (2022).10.3390/gels8020082 ↗
75. Kim, M. J., Park, S. C. & Choi, S. O. Dual-nozzle spray deposition process for improving the stability of proteins in polymer microneedles. RSC Adv. 7, 55350–55359 (2017).10.1039/C7RA10928H ↗
76. Park, S. C., Kim, M. J., Baek, S. K., Park, J. H. & Choi, S. O. Spray-formed layered polymer microneedles for controlled biphasic drug delivery. Polymers 11, 369 (2019).10.3390/polym11020369 ↗
77. McGrath, M. G. et al. Production of dissolvable microneedles using an atomised spray process: Effect of microneedle composition on skin penetration. Eur. J. Pharm. Biopharm. 86, 200–211 (2014).10.1016/j.ejpb.2013.04.023 ↗
78. Keirouz, A. et al. The History of Electrospinning: Past, Present, and Future Developments. Adv. Mater. Technol. 8, 2201723 (2023).10.1002/admt.202201723 ↗
79. Valachová, K., El Meligy, M. A. & Šoltés, L. Hyaluronic acid and chitosan-based electrospun wound dressings: Problems and solutions. Int. J. Biol. Macromol. 206, 74–91 (2022).10.1016/j.ijbiomac.2022.02.117 ↗
80. Augustine, R. et al. Electrospun chitosan membranes containing bioactive and therapeutic agents for enhanced wound healing. Int. J. Biol. Macromol. 156, 153–170 (2020).10.1016/j.ijbiomac.2020.03.207 ↗
81. Antunes, B. P., Moreira, A. F., Gaspar, V. M. & Correia, I. J. Chitosan/arginine-chitosan polymer blends for assembly of nanofibrous membranes for wound regeneration. Carbohydr. Polym. 130, 104–112 (2015).10.1016/j.carbpol.2015.04.072 ↗
82. Kolahi Azar, H. et al. Integration of polysaccharide electrospun nanofibers with microneedle arrays promotes wound regeneration: A review. Int. J. Biol. Macromol. 258, 128482 (2024).10.1016/j.ijbiomac.2023.128482 ↗
83. Fu, L. et al. Nanofibers for the Immunoregulation in Biomedical Applications. Adv. Fiber Mater. 4, 1334–1356 (2022).10.1007/s42765-022-00191-2 ↗
84. Su, Y. et al. Dissolvable Microneedles Coupled with Nanofiber Dressings Eradicate Biofilms via Effectively Delivering a Database-Designed Antimicrobial Peptide. ACS Nano 14, 11775–11786 (2020).10.1021/acsnano.0c04527 ↗
85. He, H. et al. Engineered Spindles of Little Molecules Around Electrospun Nanofibers for Biphasic Drug Release. Adv. Fiber Mater. 4, 305–317 (2022).10.1007/s42765-021-00112-9 ↗
86. Wang, Y. et al. Fiber-Reinforced Silk Microneedle Patches for Improved Tissue Adhesion in Treating Diabetic Wound Infections. Adv. Fiber Mater. 6, 1596–1615 (2024).10.1007/s42765-024-00439-z ↗
87. Xiao, S. et al. Artificial Phages with Biocatalytic Spikes for Synergistically Eradicating Antibiotic-Resistant Biofilms. Adv. Mater. 36, 2404411 (2024).10.1002/adma.202404411 ↗
88. Long, Y. et al. Hedgehog artificial macrophage with atomic-catalytic centers to combat Drug-resistant bacteria. Nat. Commun. 12, 6143 (2021).10.1038/s41467-021-26456-9 ↗
89. Kim, J. D., Kim, M., Yang, H., Lee, K. & Jung, H. Droplet-born air blowing: Novel dissolving microneedle fabrication. J. Control. Release 170, 430–436 (2013).10.1016/j.jconrel.2013.05.026 ↗
90. Drzyzga, Ł, Śpiewak, D., Dorecka, M. & Wyględowska-Promieńska, D. Available Therapeutic Options for Corneal Neovascularization: A Review. Int. J. Mol. Sci. 25, 5479 (2024).10.3390/ijms25105479 ↗
91. Parravano, M., Costanzo, E., Scondotto, G., Trifirò, G. & Virgili, G. Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update. BioDrugs 35, 673–692 (2021).10.1007/s40259-021-00499-2 ↗
92. Yang, H. et al. Rapid implantation of dissolving microneedles on an electrospun pillar array. Biomaterials 64, 70–77 (2015).10.1016/j.biomaterials.2015.06.027 ↗
93. Azizi Machekposhti, S., Mohaved, S. & Narayan, R. J. Inkjet dispensing technologies: recent advances for novel drug discovery. Expert Opin. Drug Discov. 14, 101–113 (2019).10.1080/17460441.2019.1567489 ↗
94. Ali, M., Namjoshi, S., Benson, H. A. E., Mohammed, Y. & Kumeria, T. Dissolvable polymer microneedles for drug delivery and diagnostics. J. Control. Release 347, 561–589 (2022).10.1016/j.jconrel.2022.04.043 ↗
95. Yang, H. et al. Centrifugal Lithography: Self-Shaping of Polymer Microstructures Encapsulating Biopharmaceutics by Centrifuging Polymer Drops. Adv. Healthc. Mater. 6, 1700326 (2017).10.1002/adhm.201700326 ↗
96. Fakhraei Lahiji, S. et al. Tissue Interlocking Dissolving Microneedles for Accurate and Efficient Transdermal Delivery of Biomolecules. Sci. Rep. 9, 7886 (2019).10.1038/s41598-019-44418-6 ↗
97. Huh, I. et al. Effects of two droplet-based dissolving microneedle manufacturing methods on the activity of encapsulated epidermal growth factor and ascorbic acid. Eur. J. Pharm. Sci. 114, 285–292 (2018).10.1016/j.ejps.2017.12.025 ↗
98. Lee, C. et al. Comparative Study of Two Droplet-Based Dissolving Microneedle Fabrication Methods for Skin Vaccination. Adv. Healthc. Mater. 7, 1701381 (2018).10.1002/adhm.201701381 ↗
99. Onesto, V., Di Natale, C., Profeta, M., Netti, P. A. & Vecchione, R. Engineered PLGA-PVP/VA based formulations to produce electro-drawn fast biodegradable microneedles for labile biomolecule delivery. Prog. Biomater. 9, 203–217 (2020).10.1007/s40204-020-00143-2 ↗
100. Vecchione, R. et al. Electro-drawn drug-loaded biodegradable polymer microneedles as a viable route to hypodermic injection. Adv. Funct. Mater. 24, 3515–3523 (2014).10.1002/adfm.201303679 ↗